Aarhus University logo

    • About
      • About the Nordic EMBL Partnership
      • Mission statement
      • EMBL non-tenure model
      • Contact
    • News
    • Collaborations
      • NORPOD - Postdoctoral Researcher Programme
      • NordForsk: Nordic EMBL Partnership Hub
      • How the Nordic EMBL Partnership is helping to fight COVID-19
      • Tools of the Trade Data Science Webinar Series
      • Nordic EMBL Partnership Meetings
      • Nordic EMBL Partnership Science and Art
    • Research
    • Technologies
    • Training
    • Careers
    • Internal

    Read more

    Click here to read more

    DANDRITE

    The Danish Research Institute of Translational Neuroscience (DANDRITE) is the Danish node of the Nordic EMBL Partnership, and performs basic and translational research in brain and the nervous system.

    FIMM

    The Institute for Molecular Medicine Finland (FIMM) is the Finnish node of the Nordic EMBL Partnership. FIMM’s research interests are human genomics and personalized medicine, with a focus on translational research.

    MIMS

    The Laboratory for Molecular Infection Medicine Sweden (MIMS) is the Swedish node of the Nordic EMBL Partnership. MIMS aims to strengthen Swedish research and enhance the dynamics in the field of molecular medicine.

    NCMBM

    The Norwegian Centre for Molecular Biosciences and Medicine (NCMBM) is the Norwegian node of the Nordic EMBL Partnership. NCMBM conducts molecular medicine & biotech research and works to translate these findings into clinical practice. 

    News from the Partnership


    Building Bridges 2023 - Connecting researchers to strengthen crisis preparedness

    BUILDING BRIDGES 2023: CRISIS PREPAREDNESS USING THE COVID-19 PANDEMIC AS AN EXAMPLE
    29 March 2023 - Knowledge exchange

    On 16 March 2023, the Finnish node of the Nordic EMBL Partnership for Molecular Medicine, FIMM, together with the Doctoral Program in Clinical…

    DANDRITE through 10 years: Making history with the future of Neuroscience

    Photo: Lise Balsby, AU Photo
    17 March 2023 - News type

    This month DANDRITE celebrates 10 years of existence. With a new generation of highly talented group leaders already recruited, the research center is…

    Anthony Mathelier appointed as the new Associate Director of NCMM

    NCMM's new Associate Director Anthony Mathelier. Photo: Oda Hveem
    22 February 2023 - Knowledge exchange

    NCMM group leader Anthony Mathelier will be the new Associate Director of the Centre, combined with a part-time Professor II position at the Centre…

    Clinical study demonstrates the efficacy of a drug sensitivity test in predicting treatment response in leukemia

    A microscopic image of a bone marrow sample from an AML patient. Image by Heikki Kuusanmäki.
    16 February 2023 - Research news

    A clinical trial performed in Finland has shown that a drug sensitivity test performed on patient's own cells in laboratory conditions predicts…

    Page 19 of 70.

    • Previous
    • 1
    • …
    • 18
    • 19
    • 20
    • …
    • 70
    • Next

    Upcoming Partnership Events


    No events found.

    Follow us!

    Follow us for the latest updates and insights! Join our community and stay connected with us on the following platforms

    LinkedIn
    Bluesky
    X

     

    About 

    News 

    Collaborations

    Research

    Technologies

    Training

    Careers

     

     

     

    Follow us

    X: @NordicEMBL

    LinkedIn: linkedin.com/company/nordic-embl-partnership-for-molecular-medicine

     

    The Nordic EMBL Partnership for Molecular Medicine combines the complementary research expertise of the Nordic countries with a common aim to address some of the biggest challenges in biomedicine today.

     

    Revised 21.03.2025

    © — Cookies at au.dk
    Privacy Policy
    Accessibility Statement

    15450 / i43